Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Kostakoglu

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
PET Clinics|May 10, 2016
Variables Involved in Measuring Cancer Response to TreatmentLale Kostakoglu
PET Clinics|May 10, 2016
FDG-PET Evaluation of Response to TreatmentLale Kostakoglu
Clinical Lymphoma|April 24, 2002
Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?Lale Kostakoglu
PET Clinics|May 10, 2016
Novel PET Radiotracers for Potential Use in Management of LymphomaLale Kostakoglu
Seminars in Nuclear Medicine|June 4, 2013
Radionuclide response assessment of breast cancerLale Kostakoglu
Blood|August 31, 2012
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?Andrea Gallamini, Lale Kostakoglu
Cancer|August 26, 2006
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?Morton Coleman, Lale Kostakoglu
Seminars in Nuclear Medicine|December 3, 2017
Metabolic Tumor Volume Metrics in LymphomaLale Kostakoglu, Stéphane Chauvie
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2013
Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift?Lale Kostakoglu, Andrea Gallamini
PET Clinics|May 16, 2019
PET-Derived Quantitative Metrics for Response and Prognosis in LymphomaLale Kostakoglu, Stéphane Chauvie
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
PET Clinics|May 10, 2016
Variables Involved in Measuring Cancer Response to TreatmentLale Kostakoglu
PET Clinics|May 10, 2016
FDG-PET Evaluation of Response to TreatmentLale Kostakoglu
Clinical Lymphoma|April 24, 2002
Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?Lale Kostakoglu
PET Clinics|May 10, 2016
Novel PET Radiotracers for Potential Use in Management of LymphomaLale Kostakoglu
Seminars in Nuclear Medicine|June 4, 2013
Radionuclide response assessment of breast cancerLale Kostakoglu
Blood|August 31, 2012
Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?Andrea Gallamini, Lale Kostakoglu
Cancer|August 26, 2006
Early 18F-labeled fluoro-2-deoxy-D-glucose positron emission tomography scanning in the lymphomas: changing the paradigms of treatments?Morton Coleman, Lale Kostakoglu
Seminars in Nuclear Medicine|December 3, 2017
Metabolic Tumor Volume Metrics in LymphomaLale Kostakoglu, Stéphane Chauvie
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 3, 2013
Interim 18F-FDG PET in Hodgkin lymphoma: would PET-adapted clinical trials lead to a paradigm shift?Lale Kostakoglu, Andrea Gallamini
PET Clinics|May 16, 2019
PET-Derived Quantitative Metrics for Response and Prognosis in LymphomaLale Kostakoglu, Stéphane Chauvie
Pageof 12